IP Library Granted Patent US 8,337,419
Granted Patent B2
US 8,337,419 · App. 11/244,311 · Granted Dec 25, 2012

Tissue penetration device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,337,419
App. No.
11/244,311
Granted
Dec 25, 2012
Kind
B2
Abstract

A tissue penetration device and method of using same. The tissue penetration device may optionally include sampling and analyzing functions, which may be integrated. An embodiment provides control of a lancet used for sampling blood. Electric field coils or solenoids may drive the lancet using electromagnetic force. Advancement and retraction of a lancet may be controlled by a feedback loop monitoring the position and velocity of the lancet embodiments of the lancet driver can be configured to follow a predetermined tissue lancing profile. Embodiments of the invention include a lancet and method for using a lancet to maintain the patency of the wound tract once the lancet has cut into the skin.

Claims (5)

1. A method of determining contact between a tip of a lancet and target tissue of a patient comprising:

(a) determining relative position and velocity of the lancet based on measuring relative position of the lancet with respect to time;

(b) measuring a magnitude of deceleration of the lancet during at least a portion of the inward cutting stroke of the lancing cycle and comparing the magnitude of the measured deceleration to a deceleration threshold, wherein the deceleration threshold has been determined for contact between a lancet tip and a target tissue; and

(c) determining contact if the magnitude of the measured deceleration is sufficiently greater than the deceleration threshold; wherein the deceleration threshold is determined by the deceleration of the lancet due to intrinsic frictional forces of the lancing device alone.

2. The method of claim 1 wherein the deceleration threshold is determined by observing velocity losses of the lancet when the lancet is known to be making contact with the target tissue.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2012
From: PELIKAN TECHNOLOGIES, INC.
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 028397/0099 →
RELEASE OF SECURITY INTEREST Recorded Mar 2, 2010
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 024016/0492 →
SECURITY AGREEMENT Recorded Dec 18, 2008
From: PELIKAN TECHNOLOGIES, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021998/0381 →